Related Experiment Video
Updated: Apr 30, 2026
07:01
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
928
Emergence delirium in children: an update
Souhayl Dahmani1, Honorine Delivet, Julie Hilly
1aDepartment of Anesthesiology and Intensive Care, Robert Debré University Hospital bParis Diderot University, Paris VII, Paris Sorbonne Cité cINSERM UMR 676, Robert Debré University Hospital dDepartment of Pain Management, Robert Debré University eParis Descartes University, Paris V, Paris Sorbonne Cité, Paris, France.
Current Opinion in Anaesthesiology
|May 3, 2014
Summary
Emergence delirium in children, a common anesthesia complication, can be prevented by managing preoperative anxiety and pain. Alpha-2 agonists like dexmedetomidine are recommended for treatment due to their benefits.
Area of Science:
- Pediatric Anesthesiology
- Neuroscience
- Pharmacology
Background:
- Emergence delirium (ED) is a common yet poorly understood complication following pediatric anesthesia.
- While fast-acting volatile anesthetics are suspected, evidence linking them to ED is limited.
- This review synthesizes recent research on ED in children.
Purpose of the Study:
- To review recent findings on emergence delirium in pediatric anesthesia.
- To explore the causes, prevention, and treatment of ED.
- To highlight the link between ED and long-term cognitive complications.
Main Methods:
- Literature review of recent studies on emergence delirium in children.
- Analysis of factors contributing to ED, including anesthetic agents and patient characteristics.
- Evaluation of preventive and therapeutic strategies.
Main Results:
- ED typically affects preschool children after sevoflurane or desflurane anesthesia, presenting as intense anxiety.
- Both painful and non-painful procedures can trigger ED.
- Prevention involves managing preoperative anxiety, ensuring adequate analgesia, and using intraoperative sedatives (e.g., ketamine, dexmedetomidine).
- Treatment for severe agitation may involve propofol, opioids, or dexmedetomidine, with dexmedetomidine favored for its additional benefits.
- ED shares risk factors with long-term cognitive issues, necessitating parental awareness.
Conclusions:
- Emergence delirium is a frequent and preventable complication in pediatric anesthesia.
- Effective strategies include proactive pain management and the use of alpha-2 agonists.
- Parental education regarding ED and potential long-term behavioral changes is crucial.
Related Concept Videos
01:19Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
01:18Nightmares and Night Terrors
1.0K
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
Nightmares...
1.0K
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408